lupin_pharma_logo

Lupin to set up manufacturing plant in Japan

pharmafile | March 1, 2016 | News story | Manufacturing and Production |  Japan, Lupin, manufacturing 

Indian drugmaker Lupin is, via its Japanese unit Kyowa, setting up a manufacturing unit in Japan as part of its plans to expand its presence in the country. The company said the proposed plant will be based in Tottori.

“In order to meet the rapidly growing demand of generics, the Kyowa Board has proposed the setting-up of a two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion,” Lupin said in a regulatory filing.

No financial details were disclosed.

Anjali Shukla

Related Content

Brenntag and dsm-firmenich expand biopharma vitamin partnership

Brenntag Pharma and dsm-firmenich have entered a long-term global distribution partnership covering GMP-grade vitamins for …

BioDuro establishes joint manufacturing venture with Cenra

BioDuro, a Contract Research, Development and Manufacturing Organisation (CRDMO), has established a joint venture with …

Multiple myeloma treatment approved in Japan

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and …

The Gateway to Local Adoption Series

Latest content


Five Facts about COPD

October 11, 2026